Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKIN ELEMENTS LIMITED Share Issue/Capital Change 2017

May 8, 2017

65803_rns_2017-05-08_899a5d77-1c8b-4536-8497-9d47d1b9948a.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

SKIN ELEMENTS LIMITED (SKN)

ABN

90 608 047 794

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to
be issued
2
Number of+securities issued or
to be issued (if known) or
maximum number which may be
issued
3
Principal terms of the+securities
(e.g. if options, exercise price
and expiry date; if partly paid
+securities,
the
amount
outstanding and due dates for
payment;
if
+convertible
securities, the conversion price
and dates for conversion)
Ordinary Fully Paid
3,000,000
Ordinary Fully Paid
  • See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

4
Do the+securities rank equally in
all respects from the+issue date
with an existing+class of quoted
+securities?
If the additional+securities do
not rank equally, please state:
 the date from which they do
 the extent to which they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
 the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly
identify those assets)
6a
Is the entity an+eligible entity
that has obtained security holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
Securities rank equally in all respects with existing
ordinary fully paid shares (SKN)
$0.20 per share
Acquisition of business assets of McArthur Natural
Skincare Products including Business Intellectual
Property, Stock, Designs, Key Data and Key
Technologies.
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

Appendix 3B
New issue announcement
6c
Number of
+securities issued
without security holder approval
under rule 7.1
6d
Number of
+securities issued
with security holder approval
under rule 7.1A
6e
Number of
+securities issued
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f
Number of
+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least
75% of 15 day VWAP as
calculated under rule 7.1A.3?
Include the+issue date and both
values. Include the source of the
VWAP calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration, state date on
which valuation of consideration
was released to ASX Market
Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by
ASX (refer to the definition of issue date in rule
19.12). For example, the issue date for a pro
rata entitlement issue must comply with the
applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
3,000,000
None
None
3,000,000

N/A
5 May 2017
11,482,500
5 May 2017
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

ppendix 3B
ew issue announcement
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(including
the
+securities
in
section 2 if applicable)
9
Number
and
+class
of
all
+securities not quoted on ASX
(including
the
+securities
in
section 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number +Class
21,550,001
12,943,234
42,056,766
9,275,000
6,471,617
23,028,383
SKN – ordinary fully paid
SKNESC12 – ordinary escrow 12
SKNESC24 – ordinary escrow 24
SKNO – options $0.20 ex 31/10/18
SKNOESC12 – options escrow 12
SKNOESC24 – options escrow 24
+Class
SKNUOESC12 - $0.30 30/11/19
SKNUOESC24- $0.30 30/11/19
Number +Class
6,471,617
21,028,383
SKNUOESC12 - $0.30 30/11/19
SKNUOESC24- $0.30 30/11/19
N/A

Part 2 - Pro rata issue

art 2 - Pro rata issue
11
Is
security
holder
approval
required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will
be offered
14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers
(or
subregisters)
be
aggregated
for
calculating
entitlements?

No
N/A

N/A

Ordinary Fully Paid

N/A



N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

Appendix 3
New issue announceme
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell their
entitlements in full through a
broker?
31
How do security holders sell part
of their entitlements through a
broker
and
accept
for
the
balance?
32
How do security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Issue date
N/A
N/A
N/A
N/A
N/A
5 May 2017

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities (tick one)

  • (a)  +Securities described in Part 1

  • (b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35  If the additional[+] securities are[+] securities, and the number and percentage of additional[+] equity securities, the names of the 20 largest holders of the[+] securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional  + securities setting out the number of holders in the categories

  • 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

ntities that have ticked box 34(b)
38
Number of+securities for which
+quotation is sought
39
+Class of+securities for which
quotation is sought
40
Do the+securities rank equally in
all respects from the+issue date
with an existing+class of quoted
+securities?
If the additional+securities do not
rank equally, please state:
 the date from which they do
 the
extent
to
which
they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
 the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
41
Reason for request for quotation
now
Example: In the case of restricted securities, end
of restriction period
(if issued upon conversion of
another+security, clearly identify
that other+security)
42
Number
and
+class
of
all
+securities
quoted
on
ASX
(including the+securities in clause
38)
N/A
N/A
N/A
N/A
Number +Class
  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: Craig Piercy ........................... Date: 9 May 2017 (Director/Company secretary) == == == == ==

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [391 x 361] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary 0
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities 76,550,001
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid [+] ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary
securities cancelled during that 12 month
period
“A” 76,550,001
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Appendix 3B New issue announcement

==> picture [390 x 549] intentionally omitted <==

----- Start of picture text -----

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15 11,482,500
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used
Insert number of [+] equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C” 0
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 11,482,500
Note: number must be same as shown in
Step 2
Subtract “C” 0
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C” 11,482,500
[Note: this is the remaining placement
capacity under rule 7.1]
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B New issue announcement

Part 2

==> picture [391 x 423] intentionally omitted <==

----- Start of picture text -----

Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply “A” by 0.10
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of [[+]] equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
----- End of picture text -----

==> picture [391 x 209] intentionally omitted <==

----- Start of picture text -----

Insert number of [[+]] equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E”
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A “A” x 0.10 Note: number must be same as shown in Step 2 Subtract “E” Note: number must be same as shown in Step 3 Total [“A” x 0.10] – “E” Note: this is the remaining placement capacity under rule 7.1A

  • See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013

PAGE NUMBER : 1 REPORT DATE : 05/05/2017 REPORT TIME : 13.46.22

==> picture [111 x 93] intentionally omitted <==

SKIN ELEMENTS LIMITED

INVESTOR RANGES FRIDAY 5 MAY 2017

Ranges Investors Securities

% Issued Capital

Security Code : SKN FULLY PAID ORDINARY SHARES

Totals for Security Code SKN

1 to 1000 3 601 .00
1001 to 5000 13 51,420 .24
5001 to 10000 171 1,700,164 7.89
10001 to 100000 119 4,457,816 20.69
100001 and Over 33 15,340,000 71.18
Total 339 21,550,001 100.00

The number of security investors holding less than a marketable parcel of 2703 securities ($.185 on 01/05/2017) is 7 and they hold 10701 securities.

end of report

Confidential - Link Market Services Limited

PAGE NUMBER : 1 REPORT DATE : 09/05/2017 REPORT TIME : 17.43.22

==> picture [111 x 93] intentionally omitted <==

SKIN ELEMENTS LIMITED

TOP 20 INVESTORS REPORT MONDAY 8 MAY 2017

Current % Issued
Rank Investor Balance Capital
Sec. Group: SKN - ORD ISSUED CAPITAL
1 SOVEREIGN EMPIRE PTY LTD 10,130,781 13.23%
2 LAWLEY GROUP PTY LTD 8,075,048 10.55%
3 SUNADVANCE GROUP LIMITED 5,000,250 6.53%
3 WILLPOWER TRADING LIMITED 5,000,250 6.53%
4 SOVEREIGN EQUITIES PTY LTD 4,570,325 5.97%
5 TOP OCEANIA INTERNATIONAL 3,500,000 4.57%
LIMITED
6 TOM MCARTHUR PTY LTD 3,000,000 3.92%
7 CLARE MALONE 1,500,000 1.96%
8 HEKIMA PTY LTD 1,333,333 1.74%
9 LJM CAPITAL CORPORATION PTY 1,250,000 1.63%
LTD
10 AUSTRALIAN EXECUTOR TRUSTEES 1,230,000 1.61%
LTD
11 CHENG GU 1,140,000 1.49%
12 YIDONG BAO 875,000 1.14%
12 CALIBRE CAPITAL INC. 875,000 1.14%
13 CHRIS SMAILES + 625,000 .82%
SHARON SMAILES
<SMAILES FAMILY SUPER FUND
A/C>
14 ROBIN ARMSTRONG 600,000 .78%

Confidential - Link Market Services Limited

PAGE NUMBER : 2 REPORT DATE : 09/05/2017 REPORT TIME : 17.43.22

==> picture [111 x 93] intentionally omitted <==

SKIN ELEMENTS LIMITED

TOP 20 INVESTORS REPORT MONDAY 8 MAY 2017

Current % Issued
Rank Investor Balance Capital
15 NEIL BOWIE + 500,000 .65%
TERESE BOWIE
15 IMPACT NOMINEES PTY LTD 500,000 .65%
15 LAKEHOUSE INVESTMENTS PTY LTD 500,000 .65%
15 DUNCAN MACLEAN 500,000 .65%
15 FRANK MALONE 500,000 .65%
15 JO-ANNA MALONE 500,000 .65%
15 SALLY-ANNE MALONE 500,000 .65%
15 XAVIER MALONE 500,000 .65%
15 MS JESSICA YUJIA MAO 500,000 .65%
15 MODOMIO PTY LTD 500,000 .65%
15 WHITE LINE CAPITAL PTY LTD 500,000 .65%
16 GEORGE TENNENT 487,500 .64%
17 KEITH FLYNN 461,250 .60%
<KEITH FLYNN & FAMILY SUPER
FUND A/C>
18 GUANGWEI FAN 430,000 .56%
19 GREGORACH PTY LTD 416,667 .54%

Confidential - Link Market Services Limited

PAGE NUMBER : 3 REPORT DATE : 09/05/2017 REPORT TIME : 17.43.22

==> picture [111 x 93] intentionally omitted <==

SKIN ELEMENTS LIMITED

TOP 20 INVESTORS REPORT

MONDAY 8 MAY 2017

Current % Issued
Rank Investor Balance Capital
20 RM COMPANY PTY LTD 375,000 .49%
<ROBERT MACGREGOR INVESTMENT
A/C>
Investors
TOTAL IN THIS REPORT: 56,375,404 32 73.65%
TOTAL OTHER INVESTORS: 20,174,597 417 26.35%
GRAND TOTAL: 76,550,001 449 100.00%

end of report

Confidential - Link Market Services Limited